BRAF and neoplasm: TERTp mutations, as a late event in tumor progression (55, 98), can also occur simultaneously with BRAF or RAS mutations in poorly differentiated and anaplastic thyroid cancers (99, 100), enhancing tumor aggressiveness (100–105).